Floatz logo

Keppra

Epilepsy, Post-Traumatic

Cambridge University Hospitals NHS Foundation TrustPhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Epilepsy, Post-Traumatic cohort.

Asset / SponsorPhaseRating
DPA-714
University of California, Davis
Phase 1CC

Same molecule, other indications

Keppra is also rated in:

Epilepsy, PartialDormant
A
Indicative ·
80 / 100
View asset →
Epilepsy, Tonic-clonicDormant
BBB
Indicative ·
78 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →